Deadly Wuhan Coronavirus

Discussion in 'End Times & Conspiracies' started by nivek, Jan 16, 2020.

  1. AD1184

    AD1184 Noble

    Messages:
    927
    Merck does not stand to make any money from Ivermectin. The drug is out of patent, and is produced as a generic by several manufacturers. Merck also issued the following statement regarding Ivermectin and Covid-19:

    Merck Statement on Ivermectin use During the COVID-19 Pandemic - Merck.com

     
  2. JahaRa

    JahaRa Noble

    Messages:
    899
    it is not from Japan. I hate when headlines misrepresent the real story.
    Good for them. I have worked for doctors before and Merk proved then to be quite a pushy and controlling company. I found out that they are owned by Dow chemicals when I left a flyer on the break room table that explained something Dow chemicals was doing that was causing illness. I was chastised and told never to bring that kind of material in to the office because Merk was a supporter of the doctor group.

    I am glad to see that they are not the ones selling the idea of ivermectin as a Covid remedy, AND at this point I think they would know better than some of the others, though there is a claim that Ivermectic is based on something in the soil in Japan. The whole internet information system requires quite an education to be able to know what is information and what is misinformation.
     
  3. dlw

    dlw Saved by grace

    Messages:
    485
    Early treatment is how covid can be turned around.
     
  4. AD1184

    AD1184 Noble

    Messages:
    927
    There is a large, double-blind, controlled study of ivermectin use in Covid-19 treatment underway at Oxford University. We will have to see what the result of that is. Of course, the pandemic may be over before there are any results. I have an open mind to the idea that ivermectin might be effective in the treatment of Covid-19.

    If ivermectin does prove effective, it is not going to make any one a billion dollars, though, unlike Gilead Sciences, whose dubious antiviral medicine remdesivir received emergency approval by the FDA last year (with many other countries following suit) in light of a massaged clinical study which was aborted before its previously stated end point, and to little media scrutiny from those who are hot on the case of people promoting ivermectin. Billions of dollars' worth of remdesivir was purchased by the US governments. Gilead can only dream that remdesivir had clinical results as good as ivermectin has shown, and if it did, they would be spun very differently to how ivermectin's results are being spun.
     
    Last edited: Sep 3, 2021
    • Like Like x 1
  5. nivek

    nivek As Above So Below

    Messages:
    28,184
    I've heard that is what India is using to get covid under control in their country...I have noticed their infection rates and deaths have dwindled considerably and suddenly in the time before the delta variant become a big problem in the US...

    ...
     
  6. nivek

    nivek As Above So Below

    Messages:
    28,184
  7. HAL9000

    HAL9000 Honorable

    Messages:
    288
  8. JahaRa

    JahaRa Noble

    Messages:
    899
    Merck Statement on Ivermectin use During the COVID-19 Pandemic - Merck.com

    KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:

    • No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
    • No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
    • A concerning lack of safety data in the majority of studies.
    We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.

    Indications and Usage for STROMECTOL® (ivermectin)

    Ivermectin is approved in the United States under the brand name STROMECTOL. STROMECTOL is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralisand for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus.

    STROMECTOL has no activity against adult Onchocerca volvulus parasites.
     
  9. nivek

    nivek As Above So Below

    Messages:
    28,184
  10. nivek

    nivek As Above So Below

    Messages:
    28,184
    And now he's tested negative, interesting...

    Joe Rogan Tests Negative for COVID 2 Days After Revealing Positive Test

    Conservative podcaster Joe Rogan has tested negative for COVID-19… two days after revealing he had tested positive for the virus. The host behind the popular “Joe Rogan Experience” podcast updated his Instagram followers Friday on his condition, sharing a photo of his negative diagnosis and writing, “Tested negative today! Thanks for all the kind wishes!”

     
  11. AD1184

    AD1184 Noble

    Messages:
    927
    This looks like some kind of home test. What is its sensitivity?
     
  12. nivek

    nivek As Above So Below

    Messages:
    28,184
    I think the test kit he used is this one:

    Ellume COVID-19 Home Test | Ellume

    I can't be sure though but the other tests available appear to be mail in type tests and this one linked is an at home test kit but other antigen home tests also require a 2nd test to confirm if he's using a different one...

    Heres an FAQ on results and accuracy...

    Resources | Ellume COVID-19 Home Test

    ...
     
  13. nivek

    nivek As Above So Below

    Messages:
    28,184
  14. nivek

    nivek As Above So Below

    Messages:
    28,184
    More than 100 Ontario youth sent to hospital for vaccine-related heart problems

    A report quietly released last week by Public Health Ontario (PHO) tallies the number of people in the province who have presented to hospital with heart inflammation following mRNA vaccination, and it skews heavily towards young people.

    As of Aug. 7, there were 106 incidents of myocarditis/pericarditis in Ontarians under the age of 25. That’s slightly more than half of the total of all such incidents. The report explains that PHO issued a directive in June for public health units to increase their surveillance of this side effect following reports from the United States and Israel of similar concerns unfolding in those countries.

    “The reporting rate of myocarditis/pericarditis was higher following the second dose of mRNA vaccine than after the first, particularly for those receiving the Moderna vaccine as the second dose of the series (regardless of the product for the first dose),” the report explains.

    PHO adds that the reporting rate for heart inflammation in those 18-24 was seven times higher with Moderna than with Pfizer. (The only vaccine currently used for 12- to 17-year-olds in Ontario is Pfizer.) While PHO initially worked with reports of 314 such incidents, upon further investigation they narrowed that number down to just over 200.

    There have in total been 202 emergency room visits across all age groups for such issues following vaccination, with 146 leading to hospitalization. Three of these have led to ICU admission. When it comes to older age brackets, there were 54 persons aged 25-39 included in the tally and 44 persons aged 40 and over.

    When broken down by the number of overall people who have received the vaccines, the reporting rate for this side effect is 7.4 per million for Pfizer and 20 per million for Moderna. The highlights section of the PHO report conclude with a note that “COVID-19 vaccines continue to be recommended and are highly effective at preventing symptomatic infection and severe outcomes from COVID-19 disease, which is also associated with a risk of myocarditis.”

    .
     
  15. nivek

    nivek As Above So Below

    Messages:
    28,184
    CDC study finds over 80% of US adults have some immunity to COVID, notes prior infection offers similar protection as vaccine

    A recent survey of blood donations has found that more than 80% of Americans over the age of 16 have some level of immunity to COVID-19 — a figure that could have massive implications on the country's public health policy moving forward. The survey, conducted by researchers at the U.S. Centers for Disease Control and Prevention, also found that twice as many people have been infected by the pathogen than have been officially counted, CNN reported. As of Thursday, more than 39 million Americans have tested positive for the virus.

    According to CNN, the CDC team, led by Dr. Jefferson Jones, embarked on the study to "determine how close the US might be to some kind of herd immunity." Though the news outlet was sure to mention the researchers "do not claim to have any kind of handle on that yet." They accomplished the task by testing about 1.4 million blood samples provided by 17 different blood collection organizations from all 50 states.

    Upon studying the samples, the team found that between July 2020 and May 2021, the percentage of blood samples that carried SARS-CoV-2 spike antibodies increased from 3.5% to 83.3% over that time period.

    The researchers highlighted the prominent role widespread vaccine efforts have played in raising the percentage. Though they also noted that prior infection provides similar protection against the virus.

    "Several large studies have shown that among individuals who are seropositive from prior SARS-CoV-2 infection, COVID-19 incidence is reduced by 80% to 95%, similar to vaccine efficacy estimates," they wrote.




    .
     
  16. nivek

    nivek As Above So Below

    Messages:
    28,184
    Experts warn Biden breaking his 'follow the science' pledge with vaccine pressure, as top officials resign

    FDA Resignations over White House Booster Shot Guidance A 'Mess For Administration'

    President Biden's Sept. 20 deadline for rolling out coronavirus booster shots has been marred by pushback from scientists, citing a lack of reliable scientific data, resulting in the recent resignations of two FDA senior officials. For some, the move contradicts his vow to "follow the science" on matters related to COVID policy.

    Public health experts are speaking out that keeping pace with the White House’s Sept. 20 timeline put increased pressure on scientists, who are analyzing the evidence, to proceed with the administration’s strategy and timeline, the New York Times reported. The issue was put on full display earlier this week, when two FDA officials - the director of the FDA’s Office of Vaccines Research & Review Marion Gruber, and its deputy director Phil Krause - filed their resignations from the agency.

    Gruber and Krause reportedly quit over a disagreement they had with the FDA’s top vaccine official, Peter Marks, and the Biden administration’s push to roll out the vaccine booster shots.

    The incident comes after Biden’s message of following the science was echoed across the nation last year, with Biden’s campaign website stating, "Whatever the state of the COVID pandemic on the day Joe Biden and Kamala Harris take office, their administration will: Listen to science, Ensure public health decisions are informed by public health professionals, Restore trust, transparency, common purpose, and accountability to our government."

    After the election, Biden has continued using the phrase and idea, while also touting the Sept. 20 timeline during various events with the media. Just last Friday, he said "this booster program is going to start here on September the 20th, pending approval of the FDA and then a CDC committee of outside experts."


    (More on the link)

    .
     
  17. nivek

    nivek As Above So Below

    Messages:
    28,184
    CNN panel blasts Biden admin's inability to communicate clearly on COVID: 'People feel jerked around'

    A CNN panel blasted the Biden administration on Sunday for getting ahead of the science on booster shots, noting Americans are getting "frustrated" by the haphazardness at the White House.

    President Biden proclaimed booster shots would be available to the public by September 20, yet the Food and Drug Administration (FDA) appeared to be caught off guard by that goal. They told the White House, regulators need more time to review necessary data before setting a date. The FDA is poised to approve boosters for those who got the Pfizer-BioNTech vaccine, but the wait is reportedly going to be longer for those who got the Johnson & Johnson and Moderna shots.

    Two senior officials at the agency resigned in the wake of disagreement about the deadline. Dr. Marc Siegel described it as "a mess for the administration" in a recent "America’s Newsroom" interview. "The delay may be minimal, but it is raising some concerns about the White House influence over scientific decisions," CNN's Kaitlan Collins said on Sunday's "Inside Politics."

    Wall Street Journal national politics reporter Joshua Jamerson said the voters he's spoken with are "frustrated" by the White House's changing goal posts. "There is no question people feel jerked around," is how TIME's national political correspondent Molly Ball described it. Ball suggested while everyone "understands" the administration is dealing with new variants, their handling and messaging of the new challenges has not helped matters.

    "But at the same time, there has been a clear inability to communicate clearly and consistently with the American people and particularly when so many people…were so excited to come out of this and that sort of jerked away," she said. "And again, not the administration's fault. Were people prepared and did people know what they were supposed to do next was there a clear national standard set?"

    She added that the administration has been "scrambling" to manage the changing landscape of COVID-19. "The administration had been scrambling to deal with all these unexpected situations in a way that did not inspire confidence," Ball said .

    A growing number of people are becoming dissatisfied with Biden's handling of the pandemic, according to new poll numbers. Biden's approval numbers have also declined following the disastrous withdrawal of U.S. troops from Afghanistan, which resulted in a Taliban takeover of the country and the tragic deaths of U.S. service members.

    Biden was also hit for his behavior during his meeting with gold star families, with parents accusing him of repeatedly glancing at his watch during the dignified transfer ceremony and for talking at length about his late son Beau instead of their sons and daughters. An original New York Times headline read, "Biden, Still Grieving His Son, Finds That Not Everyone Wants to Hear About It," before the outlet softened the language. It now reads, "In Invoking Beau, Biden Broaches a Loss That’s Guided His Presidency."

    .
     
  18. AD1184

    AD1184 Noble

    Messages:
    927
  19. dlw

    dlw Saved by grace

    Messages:
    485
  20. nivek

    nivek As Above So Below

    Messages:
    28,184
    Alabama man, 73, dies of heart failure after 43 ICU's across three states reject him because they are filled with COVID patients

    [​IMG]

    Ray DeMonia, 73, left, died of heart failure after being transferred more than 200 miles away from his hometown to Mississippi after there were no beds available at more than 40 hospitals within three Southern States because they were full of COVID-19 patients. His family urged others to get vaccinated against COVID-19 after the nation experienced one of its worst surges in cases August, with a recent uptick on Friday, inset.

    .
     

Share This Page